Search - tctmd.com

Displaying 21 - 40 of 204

Sort: Relevancy | Date

Presentation TCT 2022

Insights from the CLASP IID Registry

Presenter: Jörg Hausleiter

September 18, 2022

Presentation TCT 2022

TEER in Evolution – PASCAL in DMR; insights on data from CLASP IID RCT

Presenter: Scott Lim

September 18, 2022

Presentation TCT 2022

Results and benefits of aortic intervention in the US by age.

Presenter: Megan Coylewright

September 18, 2022

Presentation TCT 2022

Considerations of TAVR and SAVR by age in the US including a clinically relevant definition of Bioprosthetic Durability

Presenter: Evelio Rodriguez

September 18, 2022

Presentation TCT 2022

The Impact of Unloading: What We May Learn from the STEMI DTU RCT

Presenter: Navin Kapur

September 18, 2022

Presentation TCT 2022

Contemporary Techniques for Optimal Outcomes in High-Risk PCI

Presenter: Kate Kearney

September 18, 2022

Presentation TCT 2022

Percutaneous MCS Support for PCI in Surgically Ineligible Patients: Preliminary Results from Optimum

Presenter: Adam Salisbury

September 18, 2022

Presentation TCT 2022

Influential Trials in High-Risk PCI: Shaping the Future of Ischemic Heart Failure Therapy

Presenter: Jonathan Hill

September 18, 2022

Presentation TCT 2022

The Future of Sirolimus Coated Balloons: a look at the design of IDE clinical trials

Presenter: Azeem Latib

September 18, 2022

Presentation TCT 2022

Sirolimus Coated Balloon in real life complex settings: Case Presentations with long term FU and positive remodelling

Presenter: Sandeep Basavarajaiah

September 18, 2022

Presentation TCT 2022

Sirolimus-coated balloon: from EASTBOURNE, the Largest DCB study ever, to the next step, TRANSFORM 2 RCT

Presenter: Bernardo Cortese

September 18, 2022

Presentation TCT 2022

DCB in CAD: understanding the existing and new indications

Presenter: Antonio Colombo

September 18, 2022

Presentation TCT 2022

Sirolimus Coated Balloon with Nanolute Technology: Pre-clinical Insights and Rationale

Presenter: Aloke Finn

September 18, 2022

Presentation TCT 2022

Introduction & Session Objectives

Presenter: Martin Leon

September 18, 2022

Presentation TCT 2022

Transcatheter Self-expanding Valve Replacement in Pure Native Aortic Regurgitation: Results from a Multicenter Registry Study

Presenter: ShaoLiang Chen

September 18, 2022

Presentation TCT 2022

TARGET First: Short DAPT with Complete Revascularization Strategy

Presenter: Giuseppe Tarantini

September 18, 2022

Presentation TCT 2022

TARGET All Comers Trial 5-year Outcomes and Substudy Analysis

Presenter: Alexandra Lansky

September 18, 2022

Presentation TCT 2022

Expanding Treatment Population

Presenter: Rahul Sharma

September 17, 2022

Presentation TCT 2022

Optimizing Device Implant

Presenter: Abhijeet Dhoble

September 17, 2022

Presentation TCT 2022

Planning Device Selection

Presenter: Jacqueline Saw

September 17, 2022

Advertisement

Insights from the CLASP IID Registry

TEER in Evolution – PASCAL in DMR; insights on data from CLASP IID RCT

Results and benefits of aortic intervention in the US by age.

Considerations of TAVR and SAVR by age in the US including a clinically relevant definition of Bioprosthetic Durability

The Impact of Unloading: What We May Learn from the STEMI DTU RCT

Contemporary Techniques for Optimal Outcomes in High-Risk PCI

Percutaneous MCS Support for PCI in Surgically Ineligible Patients: Preliminary Results from Optimum

Influential Trials in High-Risk PCI: Shaping the Future of Ischemic Heart Failure Therapy

The Future of Sirolimus Coated Balloons: a look at the design of IDE clinical trials

Sirolimus Coated Balloon in real life complex settings: Case Presentations with long term FU and positive remodelling

Sirolimus-coated balloon: from EASTBOURNE, the Largest DCB study ever, to the next step, TRANSFORM 2 RCT

DCB in CAD: understanding the existing and new indications

Sirolimus Coated Balloon with Nanolute Technology: Pre-clinical Insights and Rationale

Introduction & Session Objectives

Transcatheter Self-expanding Valve Replacement in Pure Native Aortic Regurgitation: Results from a Multicenter Registry Study

TARGET First: Short DAPT with Complete Revascularization Strategy

TARGET All Comers Trial 5-year Outcomes and Substudy Analysis

Expanding Treatment Population

Optimizing Device Implant

Planning Device Selection

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content